Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,613.00
Bid: 1,613.00
Ask: 1,613.50
Change: 15.00 (0.94%)
Spread: 0.50 (0.031%)
Open: 1,595.00
High: 1,626.00
Low: 1,588.00
Prev. Close: 1,598.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Berenberg - Buy Dignity; Liberum - Buy Genus

Fri, 01st Jul 2016 08:51

LONDON (Alliance News) - The following shares received analyst recommendations Friday morning:
----------
FTSE 100
----------
JPMORGAN RAISES SMITH & NEPHEW PRICE TARGET TO 1196 (1096) PENCE - 'NEUTRAL'
----------
Investec Ups Diageo Target To 2,300p From 2,160p, Keeps Buy
----------
CITIGROUP RAISES GLAXOSMITHKLINE PRICE TARGET TO 1800 (1550) PENCE - 'BUY'
----------
CREDIT SUISSE RAISES ROLLS ROYCE PRICE TARGET TO 590 (534.3) PENCE - 'UNDERP.'
----------
CREDIT SUISSE CUTS ITV PRICE TARGET TO 200 (255) PENCE - 'OUTPERFORM'
----------
HSBC CUTS ITV PRICE TARGET TO 200 (280) PENCE - 'BUY'
----------
BERENBERG CUTS SKY PRICE TARGET TO 730 (784) PENCE - 'SELL'
----------
GOLDMAN RAISES MONDI PRICE TARGET TO 1325 (1250) PENCE - 'NEUTRAL'
----------
BERENBERG CUTS JOHNSON MATTHEY PRICE TARGET TO 3250 (3865) PENCE - 'BUY'
----------
UBS RAISES OLD MUTUAL PRICE TARGET TO 210 (200) PENCE - 'BUY'
----------
UBS CUTS AVIVA PRICE TARGET TO 400 (455) PENCE - 'NEUTRAL'
----------
UBS CUTS DIRECT LINE PRICE TARGET TO 352 (390) PENCE - 'NEUTRAL'
----------
UBS RAISES CARNIVAL PLC PRICE TARGET TO 4050 (3850) PENCE - 'BUY'
----------
FTSE 250
----------
JPMORGAN CUTS JOHN WOOD GROUP PRICE TARGET TO 570 (600) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS HOWDEN JOINERY TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 390 (570) PENCE
----------
JPMORGAN CUTS GREENE KING PRICE TARGET TO 950 (1050) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES SERCO GROUP PRICE TARGET TO 133 (130) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS GO-AHEAD GROUP PRICE TARGET TO 2390 (2427) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES NATIONAL EXPRESS PRICE TARGET TO 397 (362) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES FIRSTGROUP PRICE TARGET TO 145 (141) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS STAGECOACH GROUP TO 'UNDERWEIGHT' ('NEUTRAL'), PRICE TARGET 180 (256) PENCE
----------
JPMORGAN RAISES DAIRY CREST GROUP TO 'OVERWEIGHT' ('NEUTRAL')
----------
CITIGROUP RAISES SAFESTORE PRICE TARGET TO 440 (400) PENCE - 'BUY'
----------
PANMURE INITIATES TULLOW OIL PLC WITH 'SELL' - TARGET 210 PENCE
----------
CREDIT SUISSE RAISES TULLOW OIL PRICE TARGET TO 370 (330) PENCE - 'OUTPERFORM'
----------
Cantor Cuts Tullow Oil To Sell From Hold, Keeps Target At 163p
----------
CANACCORD CUTS MARSHALLS GROUP TO 'HOLD' ('BUY')
----------
Liberum Ups Tate & Lyle Target To 790p From 730p, Keeps Buy
----------
Liberum Ups Genus To Buy From Hold, Target To 1,750p From 1,500p
----------
GOLDMAN CUTS DS SMITH PRICE TARGET TO 390 (395) PENCE - 'NEUTRAL'
----------
TRADERS: MERRILL LYNCH RAISES ABERDEEN ASSET MANAGEMENT TO 'BUY' ('UNDERPERFORM')
----------
BERENBERG CUTS DOMINO'S PIZZA PRICE TARGET TO 400 (1200) PENCE - 'BUY'
----------
BERENBERG RAISES DIGNITY TO 'BUY' ('HOLD') - TARGET 2825 (2400) PENCE
----------
TRADERS: MACQUARIE INITIATES RIGHTMOVE WITH 'NEUTRAL'
----------
MAIN MARKET AND AIM
----------
JPMORGAN CUTS MOTHERCARE PRICE TARGET TO 180 (201) PENCE - 'OVERWEIGHT'
----------
Investec Ups Wynnstay Group To Hold From Sell, Cuts Target to 422p From 485p
----------
BERENBERG CUTS STAFFLINE TO 'HOLD' ('BUY') - TARGET 900 (1700) PENCE
----------
BERENBERG CUTS INTERSERVE TO 'HOLD' ('BUY') - TARGET 330 (520) PENCE
----------
Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
3 Jun 2024 17:20

European shares kick-off June on a high note in anticipation of ECB rate cut

GSK tumbles as Zantac lawsuits allowed to proceed

*

Read more
3 Jun 2024 17:19

Pharma, energy stocks drag London's FTSE 100; ECB rate cut hopes cap losses

FTSE 100 down 0.2%, FTSE 250 up 0.8%

*

Read more
3 Jun 2024 17:00

LONDON MARKET CLOSE: FTSE 100 down amid shaky start in New York

(Alliance News) - The FTSE 100 in London closed lower on Monday, marking a mixed start to June, with GSK firmly at the bottom of the index.

Read more
3 Jun 2024 14:01

GSK immunotherapy bowel cancer drug works for 100% of patients

(Alliance News) - An immunotherapy drug could spare bowel cancer patients the need for surgery and chemotherapy after results showed it was effective in 100% of cases.

Read more
3 Jun 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 up, while Labour commits to defence

(Alliance News) - Stock prices in London were up at midday, after data from S&P Global signalled a return to growth for the UK manufacturing sector.

Read more
3 Jun 2024 09:08

TOP NEWS: GSK vows to appeal adverse Delaware court ruling on Zantac

(Alliance News) - GSK PLC on Monday said it will appeal a US court ruling that it should face jury trials relating to cases concerning the heartburn drug, Zantac.

Read more
3 Jun 2024 08:37

LONDON MARKET OPEN: Stocks up amid slew of manufacturing PMIs

(Alliance News) - Stock prices in London opened higher on Monday, ahead of local purchasing managers index data, and comparative prints from several other major global economies.

Read more
3 Jun 2024 08:00

LONDON BRIEFING: FTSE 100 seen up; GSK defends ranitidine cancer claim

(Alliance News) - Stocks in London are set to open higher on Monday, ahead of a data-heavy week, kicked off by a slew of manufacturing purchasing managers' index readings.

Read more
3 Jun 2024 07:30

GSK to appeal Delaware ruling on jury trials in Zantac cancer cases

(Sharecast News) - GSK shares were down almost 10% on Monday after a US court ruled that jury trials could hear expert witnesses in 70,000 cases brought by cancer sufferers claiming its Zantac heartburn drug caused their condition.

Read more
1 Jun 2024 21:35

Delaware judge lets more than 70,000 Zantac lawsuits go forward

June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

Read more
1 Jun 2024 21:07

Delaware judge lets more than 70,000 Zantac lawsuits go forward

June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

Read more
31 May 2024 17:45

US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label

May 31 (Reuters) - The U.S. Food and Drug Administration approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

Read more
31 May 2024 16:01

US FDA approves Moderna's RSV vaccine, its second marketed product

May 31 (Reuters) - The U.S. Food and Drug Administration has approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

Read more
30 May 2024 20:56

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 30 (Reuters) - A third U.S. dairy worker tested positive for bird flu after exposure to infected cows, and was the first to suffer respiratory symptoms, U.S. officials said on Thursday in the latest expansion of the outbreak. Bird flu has been found in dairy cattle in nine states. This second case in a Michigan dairy worker was found through increased testing of people and cows in the state following the April 1 identification of a case in a Texas farm worker. Here's what you need to know about the outbreak.

WHY IS H5N1 OR BIRD FLU A CONCERN?

Read more
30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.